May 16, 2021

Lonnie Listonsmith

Experienced Health Expert

clinical

1 min read

Science 37, a decentralized clinical trial operating system developer, has shared it’s going public through a merger with special purpose acquisition company LifeSci Acquisition II Corp.

Upon completion of the deal, which is expected to close in the third quarter of 2021, the combined company will operate as Science 37 and will trade on the NASDAQ under the ticker symbol “SNCE.” Science 37 will have an initial enterprise value of approximately $1.05 billion.

The deal will provide the combined company with approximately $280 million in gross proceeds to support growth, including $200 million from private investment in public equity (PIPE)

Read More
1 min read

The International Classification of Diseases (ICD), an international disease classification system that is currently accepted, is a multiaxis system based on the etiology, location, pathology, and clinical manifestations of disease. For decades, the clinical trial and efficacy evaluation (CTEE) of treatment methods in modern medicine has been primarily based on this disease classification system.

In recent years, natural therapy and traditional medicine have become accepted to a limited extent as supplemental and alternative medicine. Because the concept of evidence-based medicine is widely recognized, reproducible evidence has become a sufficient condition for incorporating medical experience and treatment into modern medicine. In

Read More
1 min read

Innovative and personalized treatments are transforming the face of modern medicine. As patient populations become more targeted, clinical trial organizers are using strict criteria to precisely capture therapeutic effects in these populations. Successful study planning requires operational expertise, market understanding, contingency planning, and the right partners.

The global pandemic in 2020 brought many industrial sectors to a standstill. Although a large number of clinical trials around the world were affected by the global health emergency, biotech companies made dedicated efforts to ensure clinical trials continued as seamlessly as possible. In fact – Covid-19 aside – the number of clinical trials

Read More
1 min read

This article was originally published here

Biomed Pharmacother. 2021 Apr 10;139:111561. doi: 10.1016/j.biopha.2021.111561. Online ahead of print.

ABSTRACT

Heparin is the earliest and most widely used anticoagulant and antithrombotic drug that is still used in a variety of clinical indications. Since it was discovered in 1916, after more than a century of repeated exploration, heparin has not been replaced by other drugs, but a great progress has been made in its basic research and clinical application. Besides anticoagulant and antithrombotic effects, heparin also has antitumor, anti-inflammatory, antiviral, and other pharmacological activities. It is widely used clinically in cardiovascular and cerebrovascular

Read More
1 min read

The “diagnosis” of excited delirium, a term often used to justify and defend police brutality, disproportionately against Black people, has circulated in the medical canon for more than 25 years. It is time — past time, actually — for organized medicine to denounce its diagnostic validity and its use as a shield to justify excessive police force.

It reemerged most recently on May 25, 2020, when Minneapolis police officer Derek Chauvin killed George Floyd, an unarmed Black man, by kneeling on his neck for more than nine minutes. During that time, fellow officer Thomas Lane was heard to

Read More
lonnielistonsmith.net© All rights reserved. | Newsphere by AF themes.